EFFECT OF DURATION OF USE OF DEPOT MEDROXYPROGESTERONE ACETATE AND PSYCHOLOGICAL STRESS ON THE FEMALE SEXUAL FUNCTION

Depot medroxyprogesterone acetate (DMPA) injectable contraceptive has side effects. One of the side effects of progestin-only hormonal is sexual dysfunction. This study aimed to analyze the factors that influence the incidence of sexual dysfunction in women who use DMPA injectable contraception. This study used a quantitative correlative design with a cross-sectional approach. This study used convenience sampling to select 75 respondents that met the inclusion criteria. In this study, female sexual function index was the dependent variable, while the age, occupation, parity, last delivery, length of use, sexual traumatic experience and psychological stress were independent variables. A questionnaire was used to collect demographic data while the Female Sexual Function Index (FSFI) was used to measure the female sexual function. Data were analyzed using Chi-square and logistic regression. The results showed that there was a relationship between last delivery (p=0.041), length of DMPA use (p<0.001) and psychological stress (p=0.009) with the female sexual function, while age (p=0.441), occupation (p=0.308), parity (p=0.708) and sexual traumatic experience (p=0.502) had no relationship with the female sexual function. Multivariate analysis showed that length of use of DMPA injection as birth control (p=0.008) and stress (p=0.043) affect the occurrence of sexual dysfunction; DMPA injection users for 1-2 years and >2 years had a greater risk of experiencing sexual dysfunction when compared to those who used DMPA less than 1 year. Respondents who experienced stress were at greater risk of experiencing sexual dysfunction. This study shows that the length of DMPA use is most dominantly associated with the sexual dysfunction of women.